ArticlePLoS neglected tropical diseases2025
Effects of an integrated intervention on schistosomiasis prevalence in a rural area of Tanzania.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Community-level prevalence and determinants of Schistosoma mansoni infection in river-crossing Kebeles of Mizan-Aman Town, Southwest Ethiopia, where mass drug administration targets only school-aged children.PLoS neglected tropical diseases · 2026Article
- Integration of deworming into primary healthcare in Western Kenya: a quasi-experimental evaluation.Frontiers in public health · 2026Article
- Economic evaluation of primary health care integration and targeted mass drug administration in counties in western Kenya.Frontiers in health services · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Neglected tropical diseases have a huge impact around the world, particularly in sub-Saharan Africa. The global NTD community and countries have emphasized the importance of integrated interventions. However, findings on effectiveness of integrated interventions have been inconsistent. The study was a quasi-experimental design with repeated cross-sectional data collected from both intervention and control groups in 2020 and 2022. School-aged children from 12 schools were divided into three groups: the school-based mass drug administration (MDA) group, the school-based and community-based MDA group, and the integrated model group. A multilevel logistic regression model was employed to assess the impact of the integrated intervention on schistosomiasis prevalence, with individuals as the first level and groups as the second level. Examining the effect of the intervention on the prevalence of schistosomiasis among students, both the school-based and community-based MDA group (risk difference [RD] -13.7%; 95% confidence interval [CI] -24.5% to -2.9%; p < .05) and the integrated model group (RD -23.3%; 95% CI -32.7% to -13.9%; p < .001) showed significantly greater reductions compared to the school-based MDA alone group. In addition, the integrated model group (RD -9. 6%; 95% CI -23.3% to 4.1%; p > .05) had a greater reduction in infection rates than the school-based and community-based group. For behavior change outcomes, when comparing changes in the proportion of water contact behaviors, the integrated model group had a significantly greater reduction compared to the school-based and community-based group (RD -56.0%; 95% CI -67.3% to -44.8%; p < .05). When comparing the change in home toilet use between groups, the fully integrated model group performed significantly better than the other two groups. This study found that an integrated approach to S. haematobium elimination was consistently effective in both students and adults. Further research is required to better understand the effectiveness of integrated NTD control strategies and where improvements are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.